1 Einträge von mit immunglobulin world
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:30:14
erkannte Namen Ria STAP | Norbert Heimberger | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring more | first your | plasma plant | with award | approved approval | patients bern | treatment switzerland | factor immunglobulin | company rare | market production |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
immunglobulin (SCIg). In the U.S., Hizentra® is used to treat patients with primary immune deficiencies. Hizentra® is also undergoing the registration process for the EU and Switzerland. The immunglobulin product, which is stabilised with L-proline, world for people with hemophilia. 2013 FDA approval for Kcentra® "for urgent warfarin reversal" The American Food and Drug Administration (FDA) issues a market license for Kcentra to reverse the effects of vitamin K antagonists in
Text Inhalt Text aus URL
Log Metriken 86083
erkannte Namen Ria STAP | Norbert Heimberger | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring more | first your | plasma plant | with award | approved approval | patients bern | treatment switzerland | factor immunglobulin | company rare | market production |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
immunglobulin (SCIg). In the U.S., Hizentra® is used to treat patients with primary immune deficiencies. Hizentra® is also undergoing the registration process for the EU and Switzerland. The immunglobulin product, which is stabilised with L-proline, world for people with hemophilia. 2013 FDA approval for Kcentra® "for urgent warfarin reversal" The American Food and Drug Administration (FDA) issues a market license for Kcentra to reverse the effects of vitamin K antagonists in
Text Inhalt Text aus URL
Log Metriken 86083